Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri

Neurology

Volumn 60, Issue 1, 2003, Pages 151-

  Louis, Elie ^a   Keime Guibert, Florence ^a   Delattre, Jean Yves ^a   Sanson, Marc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BLOOD TOXICITY; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FRONTAL LOBE; GLIOSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL;

EID: 0037435508     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.151     Document Type: Article

References (6)

1. Lantos PL and Bruner JM. Gliomatosis cerebri. In: Kleihues P, Cavence WK, eds. World Health Organization classification of tumors: tumors of the nervous system. Lyon: IARC Press, 2000;92-93.
2. Kim DG, Yang HJ, Park IA, et al. Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir 1998;140:755-762.
3. Cozad SC, Townsend P, Morantz RA, Jenny AB, Kepes JJ, Smalley SR. Gliomatosis cerebri: results with radiation therapy. Cancer 1996;78:1789-1793.
4. Benjelloun Ali, Delavelle J, Lazeyras F, Dietrich PY. Possible efficacy of temozolomide in a patient with gliomatosis cerebri. Neurology 2001;57:1932-1934.
5. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-1479.
6. Baiko GM, Blisard KS, Samaha FJ. Oligodendroglial gliomatosis cerebri. Hum Pathol 1992;23:706-707.